Acadia knows the sales but the onus is on Neuren to know anything relating to safety.
If this FDA approved drug gets into a controversy, it may affect approval across the world and impacts rest of the world licensing royalties Neuren stands to make to the tune of US$300+ million.
- Forums
- ASX - General
- Its Over
Acadia knows the sales but the onus is on Neuren to know...
-
- There are more pages in this discussion • 2,296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online